Delivery Order SPE2DB22D1103-SPE2DB25FH1B2
Award Date 8/26/25
Potential Completion Date 8/27/25
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $10,627.40 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed-price, competitively awarded contract with no set-aside designation leverages AmerisourceBergen's position as a major pharmaceutical distributor supporting federal medical procurement. The work will be performed at the company's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $14,221.61 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on September 22, 2025, with final delivery required by September 23, 2025. This non-competitive delivery order utilizes firm fixed-price pricing and represents a routine pharmaceutical supply transaction under the company's existing contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $36,245.57 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This competitive, firm fixed-price delivery order was placed under a non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with particular emphasis on...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,548.16 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX. The order was placed to...
- The Defense Logistics Agency awarded a $46,648.39 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price contract with a completion date of June 17, 2025, and represents a non-set-aside award. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is...
- The Defense Logistics Agency awarded a $74,049.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) with an ultimate completion date of September 15, 2025. This competitive award, issued on September 12, 2025, carries no set-aside designation and represents a continuation of the company's role as a critical pharmaceutical supplier to federal medical procurement needs. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,036.48 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. The contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, was structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $33,016.79 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price contract represents a non-compete award and is performed at the awardee's location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order leverages AmerisourceBergen's established relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $5,533.31 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) with a firm fixed price structure. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $24,643.14 to supply BIKTARVY 50-200-25 mg tablets (30-count units) with a firm fixed price structure and completion date of September 10, 2025. This non-set-aside, competitively awarded contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The place of performance is the company's corporate office in Conshohocken,...